Postdoctoral Fellow-MSH-13570-014

The Kyprianou lab is NIH funded and is well established in the field of translational research.  The candidate post-doc will use a wide array of techniques including bioinformatics, immunohistochemical analysis of tumor tissue, pre-clinical PDX models, transgenic mouse models, isolation of extracellular vesicles  from serum, flow-cytometry and molecular biology techniques ( including RT-PCR, confocal microscopy) to define the underlying mechanisms of emergence of metastatic therapeutically resistant tumors and identify extracellular vesicles (EVs) as biomarkers of tumor progression..

As part of their academic training in translational cancer research, the post-doc will be participating in the urology research meetings, journal club, research seminar series at the Tisch Cancer Institute, at mentor guidance. Moreover the post-doc is expected to write & submit research articles for publication in urologic oncology under the mentorship of Dr. Kyprianou. It is anticipated that all or most of the experimental work will be performed at Annenberg, Floor 24.

 

The post-doctoral fellow will have duties that will include basic and translational research projects  in urologic oncology. The Kyprianou lab focuses on the investigation of novel therapeutic targeting in metastatic, castration-resistant prostate cancer and renal cancer towards overcoming advanced disease and in collaboration with Dr. Navneet Dogra’s lab are investigating the identification of novel liquid biopsies and biomarkers of therapeutic resistance (exosomes) . 

PhD or MD

 

SPOC-UAW Local 4100 at Icahn School of Medicine (Post Docs), 869 - Urology - ISM, Icahn School of Medicine